The Use of Hydroxyurea in the Treatment of COVID-19
Results In all presented cases, patients reverted to their baseline respiratory health after treatment with the hydroxyurea protocol. There was no significant difference in the correlation between COVID-19 and hydroxyurea. However, deaths were extremely low for those taking hydroxyurea.
Please note there are some strong warnings on the potential adverse effects of this drug.
Following that link to the NIH study, you should dig into the details:
From:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647674/
“The total number of reported COVID-19 cases diagnosed in patients with sickle cell disease worldwide is 359. Of the reported study population, 212 were 19 or older and the remaining 147 were 18 or below making them pediatric cases (Figure 1). Of the patients reported, 164 were male, 190 were female, and 5 did not answer and/or identify with either gender (Figure 2). Of the 359 total reported, 192 were taking hydroxyurea prior to their COVID-19 diagnosis (53.8 %) (Figure 3). Of the 192 patients taking hydroxyurea, 86 were male and 106 were female (Figure 4). Of the 192 patients taking hydroxyurea, 81 were 18 years old or younger and 111 were age 19 years or older (Figure 5). Of the 359 patients reported as of August 28th, 2020, there have been 16 fatalities. Of those 16 fatalities, 7 were taking hydroxyurea and 9 were not. When compared, the mortality rate of total patients taking hydroxyurea (192) is 3.65% compared to a mortality rate of 5.39% for total patients not taking hydroxyurea (167) (Figures 6 & 7).”
I’m not sure you have a large enough data pool to make a conclusion on this, especially with the number of other factors & variables at play (individuals age, general health, other medications/treatments being administered, etc.). I’m not saying it wouldn’t warrant review, but one one patient living vs. dying (8/8) show no affect of the hydroxurea?
Also, not looking at the ages beyond “are they above or below 18 years old” is about useless when evaluating a disease that mainly affects the elderly groups more than those under 50.
Just my $.03 (Bidenflation...)